Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum

Proprietary Educational Format:

Activity Overview

The goal of this activity is to educate physicians and other healthcare professionals on the appropriate management of patients with BCC at different disease stages.

0.75 CE Credit(s)
Expires: June 14, 2022

Target Audience

This activity is intended for oncology, dermatology, and dermato-oncology clinicians who manage patients with basal cell carcinoma (BCC).

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Distinguish between high- and low-risk BCC
  • Apply the current standard of care for treating high-risk BCC
  • Select appropriate front-line systemic therapy for advanced BCC
  • Evaluate emerging efficacy and safety data for immunotherapy in advanced BCC, offering clinical trial enrollment where appropriate

Activity Faculty

Gutzmer

Prof. Ralf Gutzmer, MD (Chair)

Director
Department of Dermatology
Skin Cancer Center Minden
Johannes-Wesling-Klinikum Minden/Ruhr-University Bochum
Minden, Germany

Bassett

Prof. Nicole Basset-Seguin, MD, PhD

Policlinique de Dermatologie
Hôpital Saint-Louis
Université de Paris
Paris, France

Hamid

Omid Hamid, MD

Chief of Research/Immuno-Oncology
The Angeles Clinic & Research Institute
Co-Director, Cutaneous Malignancy Program
Cedars-Sinai CANCER
Los Angeles, California, United States

Thomas Hunter (Patient)